#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Cognitive Dysfunction Is Sustained after Rescue Therapy in Experimental Cerebral Malaria, and Is Reduced by Additive Antioxidant Therapy


Neurological impairments are frequently detected in children surviving cerebral malaria (CM), the most severe neurological complication of infection with Plasmodium falciparum. The pathophysiology and therapy of long lasting cognitive deficits in malaria patients after treatment of the parasitic disease is a critical area of investigation. In the present study we used several models of experimental malaria with differential features to investigate persistent cognitive damage after rescue treatment. Infection of C57BL/6 and Swiss (SW) mice with Plasmodium berghei ANKA (PbA) or a lethal strain of Plasmodium yoelii XL (PyXL), respectively, resulted in documented CM and sustained persistent cognitive damage detected by a battery of behavioral tests after cure of the acute parasitic disease with chloroquine therapy. Strikingly, cognitive impairment was still present 30 days after the initial infection. In contrast, BALB/c mice infected with PbA, C57BL6 infected with Plasmodium chabaudi chabaudi and SW infected with non lethal Plasmodium yoelii NXL (PyNXL) did not develop signs of CM, were cured of the acute parasitic infection by chloroquine, and showed no persistent cognitive impairment. Reactive oxygen species have been reported to mediate neurological injury in CM. Increased production of malondialdehyde (MDA) and conjugated dienes was detected in the brains of PbA-infected C57BL/6 mice with CM, indicating high oxidative stress. Treatment of PbA-infected C57BL/6 mice with additive antioxidants together with chloroquine at the first signs of CM prevented the development of persistent cognitive damage. These studies provide new insights into the natural history of cognitive dysfunction after rescue therapy for CM that may have clinical relevance, and may also be relevant to cerebral sequelae of sepsis and other disorders.


Vyšlo v časopise: Cognitive Dysfunction Is Sustained after Rescue Therapy in Experimental Cerebral Malaria, and Is Reduced by Additive Antioxidant Therapy. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000963
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000963

Souhrn

Neurological impairments are frequently detected in children surviving cerebral malaria (CM), the most severe neurological complication of infection with Plasmodium falciparum. The pathophysiology and therapy of long lasting cognitive deficits in malaria patients after treatment of the parasitic disease is a critical area of investigation. In the present study we used several models of experimental malaria with differential features to investigate persistent cognitive damage after rescue treatment. Infection of C57BL/6 and Swiss (SW) mice with Plasmodium berghei ANKA (PbA) or a lethal strain of Plasmodium yoelii XL (PyXL), respectively, resulted in documented CM and sustained persistent cognitive damage detected by a battery of behavioral tests after cure of the acute parasitic disease with chloroquine therapy. Strikingly, cognitive impairment was still present 30 days after the initial infection. In contrast, BALB/c mice infected with PbA, C57BL6 infected with Plasmodium chabaudi chabaudi and SW infected with non lethal Plasmodium yoelii NXL (PyNXL) did not develop signs of CM, were cured of the acute parasitic infection by chloroquine, and showed no persistent cognitive impairment. Reactive oxygen species have been reported to mediate neurological injury in CM. Increased production of malondialdehyde (MDA) and conjugated dienes was detected in the brains of PbA-infected C57BL/6 mice with CM, indicating high oxidative stress. Treatment of PbA-infected C57BL/6 mice with additive antioxidants together with chloroquine at the first signs of CM prevented the development of persistent cognitive damage. These studies provide new insights into the natural history of cognitive dysfunction after rescue therapy for CM that may have clinical relevance, and may also be relevant to cerebral sequelae of sepsis and other disorders.


Zdroje

1. HuntNH

GolenserJ

Chan-LingT

ParekhS

RaeC

2006 Immunopathogenesis of cerebral malaria. Int J Parasitol 36 569 582

2. GolenserJ

McQuillanJ

HeeL

MitchellAJ

HuntNH

2006 Conventional and experimental treatment of cerebral malaria. Int J Parasitol 36 583 593

3. van HensbroekMB

PalmerA

JaffarS

SchneiderG

KwiatkowskiD

1997 Residual neurologic sequelae after childhood cerebral malaria. J Pediatr 131 125 129

4. BoivinMJ

BangiranaP

ByarugabaJ

OpokaRO

IdroR

2007 Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics 119 e360 366

5. CarterJA

LeesJA

GonaJK

MuriraG

RimbaK

2006 Severe falciparum malaria and acquired childhood language disorder. Dev Med Child Neurol 48 51 57

6. CarterJA

Mung'ala-OderaV

NevilleBG

MuriraG

MturiN

2005 Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry 76 476 481

7. DugbarteyAT

SpellacyFJ

DugbarteyMT

1998 Somatosensory discrimination deficits following pediatric cerebral malaria. Am J Trop Med Hyg 59 393 396

8. HoldingPA

StevensonJ

PeshuN

MarshK

1999 Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg 93 529 534

9. DesruisseauxMS

GulinelloM

SmithDN

LeeSC

TsujiM

2008 Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J Infect Dis 197 1621 1627

10. SchofieldL

GrauGE

2005 Immunological processes in malaria pathogenesis. Nat Rev Immunol 5 722 735

11. EngwerdaC

BelnoueE

GrunerAC

ReniaL

2005 Experimental models of cerebral malaria. Curr Top Microbiol Immunol 297 103 143

12. de KossodoS

GrauGE

1993 Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol 151 4811 4820

13. LiC

SeixasE

LanghorneJ

2001 Rodent malarias: the mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite. Med Microbiol Immunol 189 115 126

14. BeckerK

TilleyL

VennerstromJL

RobertsD

RogersonS

2004 Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 34 163 189

15. PinoP

VouldoukisI

DugasN

Hassani-LoppionG

DugasB

2003 Redox-dependent apoptosis in human endothelial cells after adhesion of Plasmodium falciparum-infected erythrocytes. Ann N Y Acad Sci 1010 582 586

16. WieseL

KurtzhalsJA

PenkowaM

2006 Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol 200 216 226

17. HopkinsRO

JacksonJC

2006 Long-term neurocognitive function after critical illness. Chest 130 869 878

18. PamplonaA

FerreiraA

BallaJ

JeneyV

BallaG

2007 Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13 703 710

19. LacknerP

BeerR

HeusslerV

GoebelG

RudzkiD

2006 Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol 32 177 188

20. BarichelloT

MartinsMR

ReinkeA

FeierG

RitterC

2005 Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med 33 221 223; discussion 262–223

21. ShearHL

MarinoMW

WanidworanunC

BermanJW

NagelRL

1998 Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria. Am J Trop Med Hyg 59 852 858

22. BelnoueE

KayibandaM

VigarioAM

DescheminJC

van RooijenN

2002 On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol 169 6369 6375

23. RandallLM

AmanteFH

McSweeneyKA

ZhouY

StanleyAC

2008 Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities. Infect Immun 76 3312 3320

24. IzquierdoI

BarrosDM

Mello e SouzaT

de SouzaMM

IzquierdoLA

1998 Mechanisms for memory types differ. Nature 393 635 636

25. BermpohlD

HalleA

FreyerD

DagandE

BraunJS

2005 Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest 115 1607 1615

26. HalliwellB

2006 Oxidative stress and neurodegeneration: where are we now? J Neurochem 97 1634 1658

27. TaoufiqZ

PinoP

DugasN

ContiM

TefitM

2006 Transient supplementation of superoxide dismutase protects endothelial cells against Plasmodium falciparum-induced oxidative stress. Mol Biochem Parasitol 150 166 173

28. RosenthalPJ

2008 Artesunate for the treatment of severe falciparum malaria. N Engl J Med 358 1829 1836

29. MurphySC

BremanJG

2001 Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 64 57 67

30. PenetMF

ViolaA

Confort-GounyS

Le FurY

DuhamelG

2005 Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci 25 7352 7358

31. GlicksteinM

BerlucchiG

2008 Classical disconnection studies of the corpus callosum. Cortex 44 914 927

32. JohnCC

BangiranaP

ByarugabaJ

OpokaRO

IdroR

2008 Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics 122 e92 99

33. SanniLA

FuS

DeanRT

BloomfieldG

StockerR

1999 Are reactive oxygen species involved in the pathogenesis of murine cerebral malaria? J Infect Dis 179 217 222

34. NahrevanianH

DascombeMJ

2001 Nitric oxide and reactive nitrogen intermediates during lethal and nonlethal strains of murine malaria. Parasite Immunol 23 491 501

35. CordeiroRS

Assreuy FilhoJ

FloresCA

CunhaFQ

MartinsMA

1984 Pulmonary edema in mice infected with Plasmodium berghei. Involvement of catecholamines. Experientia 40 301 302

36. SarfoBY

ArmahHB

IruneI

AdjeiAA

OlverCS

2005 Plasmodium yoelii 17XL infection up-regulates RANTES, CCR1, CCR3 and CCR5 expression, and induces ultrastructural changes in the cerebellum. Malar J 4 63

37. MartinsYC

CarvalhoLJ

Daniel-RibeiroCT

2009 Challenges in the determination of early predictors of cerebral malaria: lessons from the human disease and the experimental murine models. Neuroimmunomodulation 16 134 145

38. BudsonAE

PriceBH

2005 Memory dysfunction. N Engl J Med 352 692 699

39. ViannaMR

AlonsoM

ViolaH

QuevedoJ

de ParisF

2000 Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn Mem 7 333 340

40. JarrardLE

1995 What does the hippocampus really do? Behav Brain Res 71 1 10

41. SquireLR

Zola-MorganS

1991 The medial temporal lobe memory system. Science 253 1380 1386

42. HeidbrederCA

GroenewegenHJ

2003 The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 27 555 579

43. MogensenJ

MoustgaardA

KhanU

WortweinG

NielsenKS

2005 Egocentric spatial orientation in a water maze by rats subjected to transection of the fimbria-fornix and/or ablation of the prefrontal cortex. Brain Res Bull 65 41 58

44. IzquierdoI

MedinaJH

1995 Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol Learn Mem 63 19 32

45. IzquierdoI

MedinaJH

1997 Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 68 285 316

46. EnnaceurA

DelacourJ

1988 A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 31 47 59

47. RosaRM

FloresDG

AppeltHR

BragaAL

HenriquesJA

2003 Facilitation of long-term object recognition memory by pretraining administration of diphenyl diselenide in mice. Neurosci Lett 341 217 220

48. LaatuS

RevonsuoA

JaykkaH

PortinR

RinneJO

2003 Visual object recognition in early Alzheimer's disease: deficits in semantic processing. Acta Neurol Scand 108 82 89

49. FailleD

El-AssaadF

AlessiMC

FusaiT

CombesV

2009 Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost 102 1093 1102

50. PotterSM

MitchellAJ

CowdenWB

SanniLA

DinauerM

2005 Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections. Infect Immun 73 4941 4947

51. FavreN

RyffelB

RudinW

1999 The development of murine cerebral malaria does not require nitric oxide production. Parasitology 118 ( Pt 2) 135 138

52. MohantyS

PatelDK

PatiSS

MishraSK

2006 Adjuvant therapy in cerebral malaria. Indian J Med Res 124 245 260

53. HalliwellB

2007 Biochemistry of oxidative stress. Biochem Soc Trans 35 1147 1150

54. RitterC

AndradesME

ReinkeA

Menna-BarretoS

MoreiraJC

2004 Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 32 342 349

55. BarichelloT

MachadoRA

ConstantinoL

ValvassoriSS

ReusGZ

2007 Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med 35 2186 2190

56. De FloraS

IzzottiA

D'AgostiniF

CesaroneCF

1991 Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer. Am J Med 91 122S 130S

57. AruomaOI

HalliwellB

HoeyBM

ButlerJ

1989 The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6 593 597

58. HalliwellB

1987 Oxidants and human disease: some new concepts. FASEB J 1 358 364

59. HalliwellB

1989 Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic Biol Med 7 645 651

60. MuD

ChangYS

VexlerZS

FerrieroDM

2005 Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol 195 407 415

61. PrassK

RuscherK

KarschM

IsaevN

MegowD

2002 Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22 520 525

62. TeixeiraLK

FonsecaBP

Vieira-de-AbreuA

BarbozaBA

RobbsBK

2005 IFN-gamma production by CD8+ T cells depends on NFAT1 transcription factor and regulates Th differentiation. J Immunol 175 5931 5939

63. RogersDC

FisherEM

BrownSD

PetersJ

HunterAJ

1997 Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8 711 713

64. QuevedoJ

ViannaMR

RoeslerR

de-ParisF

IzquierdoI

1999 Two time windows of anisomycin-induced amnesia for inhibitory avoidance training in rats: protection from amnesia by pretraining but not pre-exposure to the task apparatus. Learn Mem 6 600 607

65. TuonL

ComimCM

PetronilhoF

BarichelloT

IzquierdoI

2008 Memory-enhancing treatments reverse the impairment of inhibitory avoidance retention in sepsis-surviving rats. Crit Care 12 R133

66. TuonL

ComimCM

PetronilhoF

BarichelloT

IzquierdoI

2008 Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med 34 1724 1731

67. SchroderN

O'DellSJ

MarshallJF

2003 Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 49 89 96

68. DraperHH

HadleyM

1990 Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186 421 431

69. PuhlH

WaegG

EsterbauerH

1994 Methods to determine oxidation of low-density lipoproteins. Methods Enzymol 233 425 441

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 6
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#